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Objectives: Because the autonomic nervous system is an important determinant in
the appearance of atrial fibrillation, we have assessed the role of ventral cardiac
denervation for its prevention.
Methods: Patients undergoing low-risk coronary artery surgery were enrolled. No
routine antiarrhythmic drugs were administered before or after the operation.
Ventral cardiac denervation was performed in 207 patients, and 219 patients were
used as control subjects. Denervation was performed before cardiopulmonary by-
pass. The groups were comparable regarding demographic, clinical, and operative
variables.
Results: The additional time for the denervation was 5  2 minutes, and there
were no associated complications. Postoperative atrial fibrillation was present in
15 (7%) patients undergoing ventral cardiac denervation (95% confidence in-
terval, 4%-12%) and in 56 (27%) control subjects (95% confidence interval,
18%-35%). Patients submitted to ventral cardiac denervation had fewer and less
severe episodes of atrial fibrillation, and no patient had atrial fibrillation after
discharge. Ventral cardiac denervation was the most significant predictor of
postoperative atrial fibrillation (odds ratio, 0.42; confidence interval, 0.23-0.78;
P  .006). Age of greater than 65 years (odds ratio, 1.67; confidence interval,
0.96-2.9; P  .067) was a highly suggestive predictor. The analysis of the effect
of ventral cardiac denervation correlated with the patient’s age showed a more
pronounced effect in patients younger than 70 years (odds ratio, 0.43; confidence
interval, 0.22-0.86; P  .022)
Conclusions: Ventral cardiac denervation is a fast and low-risk procedure. Its use
significantly reduces the incidence and severity of atrial fibrillation after routine
coronary artery bypass surgery. Patients younger than 70 years of age are expected
to have a higher success rate than those older than 70 years.
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Atrial fibrillation is the most common mor-bid event after coronary artery bypassgrafting. Its incidence ranges from 19% to27%, as reported by the Society of Tho-racic Surgeons database. Many groupshave tried to understand and treat this
difficult problem and have formulated different hypotheses
to explain its origin. An imbalance of the autonomic ner-
vous system after surgical intervention has been accepted as
a major determinant for this phenomenon.1-3
We designed a study to assess the role of partial ventral
cardiac denervation in reducing the incidence of postoper-
ative atrial fibrillation in patients undergoing coronary ar-
tery bypass grafting.
Material and Methods
Four hundred twenty-six patients from 3 different institutions were
enrolled in a prospective nonrandomized study. Eligible patients
were those submitted to coronary artery bypass grafting and pre-
senting a Euroscore of less than 5. Patients with a previous history
of atrial arrhythmias were excluded from this study.
The criteria used for the definition and classification of atrial
fibrillation were those recently proposed by the Committee for the
Development of Guidelines for the Management of Patients with
Atrial Fibrillation.4
Prophylactic medication for the prevention of atrial fibrillation
was not given before or after surgical intervention. Patients who
had been receiving -blockers before the operation did not inter-
rupt the treatment, which was resumed immediately after the
operation.
The demographics and hemodynamic characteristics of the 2
groups are described in Table 1.
Surgical Technique
After median sternotomy, the heart was exposed, and ventral
cardiac denervation was performed. Ventral cardiac denervation is
achieved by removing the nerves around the large vessels of the
base of the heart that run from the right side of the superior vena
cava and end at the level of the midportion of the anterior pulmo-
nary artery. This was done by excising the fat pads that surround
the superior vena cava, the aorta, and the anterior and right lateral
aspects of the main pulmonary artery (Figure 1).
The dissection started at the right side of the pericardial cavity,
and the superior vena cava was completely dissected and freed
from the right pulmonary artery. Then the fat pad around the aorta
was entirely dissected. Finally, all the fatty tissues in the aorta-
pulmonary groove and the inner half of the adventitia of the
anterior pulmonary artery up to its left border were cut.
Ventral cardiac denervation was performed in 207 patients who
provided informed consent, and 219 patients were used as control
subjects.
After this procedure, conventional coronary artery bypass graft-
ing was performed either with or without cardiopulmonary bypass
under normothermia or moderate hypothermia. Myocardial pro-
tection was achieved by using either blood or crystalloid cardio-
plegia.
The 2 groups were comparable regarding the operative data
(Table 2).
Detection of atrial fibrillation after surgical intervention was
based on patients’ complaints and on daily electrocardiograms
obtained for all patients. Telemetry was used in 34% of patients
(35% in the ventral cardiac denervation group and 33% in the
control group) for the first 4 postoperative days and for the whole
hospital admission period in 15% of the patients in both groups.
Statistical Analysis
Variables were expressed as frequencies and percentages for dis-
crete factors, mean values for normally distributed continuous
factors, and median values (25th and 75th percentiles) for contin-
uous factors of nonparametric distribution.
Statistical comparison of baseline characteristics and outcomes
was performed by using the 2-tailed 2 test with the Yates correc-
tion or the Fisher exact test for categoric variables and the 2-tailed
Student t test for continuous variables. Unpaired nonparametric
variables were compared by using the Mann-Whitney test.
Odds ratios (ORs) with 95% confidence intervals (CIs) were
calculated for the occurrence of postoperative atrial fibrillation in
relation to treatment group (ventral cardiac denervation vs con-
trol).
Multivariate logistic regression analysis was used to identify
the independent predictors of postoperative atrial fibrillation
among the following factors: age, sex, diabetes, hypertension,
chronic obstructive pulmonary disease, extent and severity of
coronary artery disease, left ventricular systolic function, treatment
group, hospital, surgeon, use and type of cardiopulmonary bypass,
type of cardioplegia, duration of myocardial ischemia, number and
type of grafts, preoperative antiarrhythmic medication, and preop-
erative and postoperative blood magnesium levels.
A subgroup analysis was performed to evaluate the interaction
between patient age and the effect of ventral cardiac denervation
on the prevention of postoperative atrial fibrillation. The same was
done to test for an interaction between prior use of -blocker drugs
and the effect of the surgical procedure.
TABLE 1. Demographics and clinical characteristics of the
patients
VCD group Control group P value
Age (y) 60 10 62 8 .190
Male sex (%) 76 75 .899
EuroSCORE 1.3 0.4 1.5 0.8 .068
Hypertension (%) 36 40 .458
COPD (%) 3 2 .729
Diabetes (%) 26 27 .902
Left main disease (%) 14 16 .663
Three-vessel disease (%) 72 66 .222
Two-vessel disease (%) 14 18 .325
LV function (%) .121
Good 50 89 87
30  moderate  50 8 5
Poor 30 3 8
AA medication (-blockers) (%) 75 81 .176
Magnesium level (mmol/L) 0.86 0.03 0.8 0.07 .003
VCD, Ventral cardiac denervation; COPD, chronic obstructive pulmonary
disease; LV, left ventricular; AA, anti-arrhythmic.
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Statistical analysis was performed with the SPSS system 9.0
(SPSS Inc, Chicago, Ill).
Results
In-hospital mortality occurred in 5 patients, 2 in the dener-
vation group and 3 in the control group, resulting from
sepsis (n  2), low cardiac output (n  1), and cerebrovas-
cular accident (n  2).
The additional length of time required for the denerva-
tion was, on average, 5  2 minutes, and there were no
complications associated with the procedure.
There was no significant excess bleeding, and the post-
operative blood drainage was similar in both groups (see
Table 3).
A total of 71 patients experienced postoperative atrial
fibrillation. This occurred in 7% (95% CI, 4%-12%) of
patients in the active treatment group versus 27% (95% CI,
18%-35%) in the control group (P  .001).
The episodes of atrial fibrillation were either paroxysmal
or persistent. All patients in whom atrial fibrillation was
diagnosed were treated with amiodarone or -blocking
agents.
In the denervation group postoperative atrial fibrillation
was paroxysmal in 3 patients and persistent in the remaining
12. After discharge, no patient required readmission for the
treatment of atrial fibrillation.
Fifty-six patients in the control group had atrial fibrilla-
tion: 2 had paroxysmal and 54 had persistent atrial fibrilla-
tion. Eleven of the 54 patients with persistent atrial fibril-
lation required additional electrical cardioversion for
rhythm control. Five patients were readmitted after dis-
charge because of atrial fibrillation. Three of these had
experienced either paroxysmal (n  2) or persistent (n  1)
atrial fibrillation during hospitalization.
Of all the potential predictors of postoperative atrial
fibrillation, only age of greater than 65 years (OR, 1.73;
95% CI, 1.02-2.93; P  .05) and ventral cardiac denerva-
tion (OR, 0.40; 95% CI, 0.23-0.74; P  .004) were signif-
icant prognostic factors for the development of postopera-
tive atrial fibrillation. Ventral cardiac denervation remained
an independent predictor of postoperative atrial fibrillation
after adjustment for the effects of all the variables tested
(OR, 0.42; 95% CI, 0.23-0.78; P  .006) and was the most
significant negative predictor of postoperative atrial fibril-
lation. Age of greater than 65 years (OR, 1.67; 95% CI,
0.96-2.9; P  .067) showed an important trend for predict-
ing postoperative atrial fibrillation.
A significant interaction was observed between patient
age and the protective effect of ventral cardiac denervation.
Figure 1. Diagram of the technique of ventral cardiac denerva-
tion. Arrows show the areas of dissection.
TABLE 2. Operative data
VCD group Control group P value
Operation with CPB (%) and
normothermia 58 52 .258
moderate hypothermia 24 27 .554
Cardioplegia (%) .586
Blood 76 73
Crystalloid 24 27
Off-pump (%) 18 21 .512
Grafts per patient 3.2 0.4 2.9 0.1 .001
Arterial grafts per patient 1.1 0.3 1 0.2 .001
Myocardial ischemia (min) 53 18 50 20 .105
Duration of CPB (min) 95 19 99 19 .030
VCD, Ventral cardiac denervation; CPB, cardiopulmonary bypass.
TABLE 3. Postoperative data
VCD group Control group
P
value
Mortality (%) 0.9 1.3 .947
Denervation (min) 5 2 –
Blood drainage (mL) 946 157 941 124 .706
CPK-MB 855 103/34 6 750 98/50 6 .001
Troponin (ng/mL) 0.6 0.4 0.7 0.2 .001
Magnesium (mmol/L)
Day 1 0.73 0.05 0.8 0.04 .001
Day 3 1.2 0.02 1.3 0.03 .001
Hospital stay (d) 8 2.5 8 3 .624
VCD, Ventral cardiac denervation; CPK-MB, creatine phosphokinase MB
fraction.
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In patients younger than 70 years of age, the overall post-
operative incidence of atrial fibrillation was 16.6%. In this
age group ventral cardiac denervation was associated with a
significant reduction in the incidence of postoperative atrial
fibrillation: 10.5% versus 21.4% for patients in the control
group (OR, 0.43; 95% CI, 0.22-0.86; P  .022). In patients
70 years or older, ventral cardiac denervation determined a
nonsignificant reduction in the incidence of postoperative
atrial fibrillation (P  .142).
No significant interaction was observed between the
treatment effect of ventral cardiac denervation and prior
medication with a -blocking drug (P  .847 for the inter-
action test). Patients previously treated with a -blocker
derived significant benefit from ventral cardiac denervation
for the prevention of postoperative atrial fibrillation (OR,
0.45; 95% CI, 0.23-0.87; P  .025). The relatively small
group of patients not receiving a -blocking drug before
surgical intervention seemed to derive similar benefit from
ventral cardiac denervation (OR, 0.29; 95% CI, 0.09-1.01; P
 .083)
Discussion
The intrapericardial epicardic nerves of the heart have been
described extensively. However, some aspects of its phys-
iology still remain unclear.5-7
Cardiac denervation is a surgical procedure described by
Arnulff in 1936.8 It was widely performed in the 1970s for
the prevention of coronary artery spasms. There are several
published studies reporting results of this surgical tech-
nique, and although its safety was well established,9,10 no
mention was made of the postoperative rhythm of the pa-
tients. Amano and colleagues11 studied the effects of intra-
pericardial cardiac denervation on the flow of coronary
artery bypass grafts and showed its beneficial effect on
systemic hemodynamics and coronary circulation as a result
of vasodilatation of the distal arterioles. The knowledge
about the type of axons included in the nerves of the ventral
plexus is very limited and requires further clarification to
fully understand the pathophysiology of its function.
Performing this operation in a more limited fashion
makes it very safe and fast. No procedure-related compli-
cations, namely excess bleeding, were observed. The re-
ported incidence of postoperative atrial fibrillation after
coronary artery bypass grafting varies from 5% to 40%.3 A
limitation of our study is related to the method of detection
of atrial fibrillation because events of atrial fibrillation
might have been undetected, either because they where
asymptomatic or because not all patients were undergoing
telemetry control. However, because of the large size of our
cohort of patients, this limitation is partially overcome in
our study.
The methods used to diagnose atrial fibrillation appear to
have a significant influence on this reported incidence. Ap-
proximately 15% of the patients in our series presented with
asymptomatic or paroxysmal atrial fibrillation, and only
telemetry allowed its diagnosis.
Many factors have been thought to correlate with the
incidence of atrial fibrillation. Of these, only age is a con-
sistent independent predictor for the occurrence of atrial
fibrillation after coronary artery bypass grafting.12,13 Other
factors, such as sex, hypertension, the use of -blocking
agents, the duration of cardiopulmonary bypass, off-pump
surgery, net fluid balance, magnesium levels before and
after the operation, prophylaxis with amiodarone, atrial
ischemia, and atrial pacing have been quoted as being
determinants of the incidence of postoperative atrial fibril-
lation. Yet there are conflicting reports on these issues,12-23
and in some instances, their documented beneficial effect is
limited.24-28
Some of the abovementioned factors were present in
both groups in our study and were not significant predictors
for the occurrence of postoperative atrial fibrillation. The
only significant factors for the occurrence of postoperative
atrial fibrillation were ventral cardiac denervation and age.
Hogue and associates1 have shown that patients who
have atrial fibrillation after coronary artery bypass graft
surgery have reduced heart rate complexity, higher heart
rates, and more frequent atrial ectopy before the onset of the
arrhythmia.
Previous studies have shown that decreased RR interval
variability and premature atrial contractions are associated
with an increased incidence of postoperative atrial fibrilla-
tion, thus reinforcing the concept that an autonomic nervous
system imbalance is at the origin or is a mediator of atrial
fibrillation.2 It should be noted that some of these mecha-
nisms are related to the stress induced by an operation or
caused by cardiopulmonary bypass.29,30
It was also surprising to observe a more pronounced
effect of ventral cardiac denervation when performed on
patients younger than 70 years of age. Although surprising,
this should not be unexpected because it is well known that
older persons, although having the same number of nerves
as younger persons, have less axons per nerve. Those mor-
phologic features might explain the better results of ventral
cardiac denervation when used in younger patients.
Another clinically significant observation was that the
incidence and severity of atrial fibrillation episodes after
coronary artery bypass grafting was significantly reduced as
a result of the denervation procedure. It is noteworthy that
in addition to the absolute number of episodes being
smaller, they were also less severe. In the group of patients
submitted to ventral cardiac denervation, cardioversion was
always achieved solely with medical therapy, thus avoiding
the need for electrical cardioversion. The fact that no hos-
pital readmissions were required as a result of the late
development of atrial fibrillation is also very encouraging.
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This experience reinforces the concept that the auto-
nomic nervous system plays an important role in the devel-
opment of postoperative atrial fibrillation. The mechanisms
underlying its action are still to be determined, but it should
be pointed out that by performing ventral partial cardiac
denervation, we were able to reduce the incidence and
severity of atrial fibrillation after routine coronary artery
bypass grafting.
In summary, we conclude that ventral cardiac denerva-
tion is a fast and low-risk procedure that significantly re-
duces the incidence of atrial fibrillation after routine coro-
nary artery bypass surgery.
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Discussion
Dr R. Damiano (St Louis, Mo). Postoperative atrial fibrillation
remains a vexing clinical problem and a significant source of
morbidity and increased hospital costs after cardiac surgery. I
congratulate Dr Melo and his group for examining a novel surgical
approach, partial cardiac denervation, in an attempt to decrease the
incidence of this common complication. This was a beautifully
presented study, and I would like to thank Dr Melo for providing
me the manuscript in advance to read before this meeting.
I have several questions regarding the study. First, in terms of
study design, this was a prospective but nonrandomized trial. How
did you exclude selection bias as a variable that might have
affected your results, and particularly, were the postoperative
caregivers blinded to the intraoperative treatment?
Second, the study does have a weakness in that only 15% of
patients had telemetry during their entire hospital stay. Did this
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perhaps result in an underreporting of atrial fibrillation? In the
manuscript you did state that 15% of patients received diagnoses
on the basis of telemetry alone, and thus this small group of
patients who had continuous telemetry might have had an undo
influence on the study outcome.
My third question is that one of the major complications
associated with postoperative atrial fibrillation is its negative effect
on both hospital stay and overall costs after coronary revascular-
ization. Did you look at either of these parameters in this prospec-
tive study?
Finally, cardiac innervation is extensive, and this limited ap-
proach clearly does not completely denervate the heart. Do you
think that partial cardiac denervation affects primarily parasympa-
thetic or sympathetic fibers? In any subgroup of patients, were any
provocative tests performed to evaluate the extent of denervation?
Also, were any of the electrophysiologic manifestations of auto-
nomic imbalance measured, particularly RR variability, P-wave
alternans, and premature atrial contractions?
I congratulate you again on a very nice study and your inves-
tigation of novel approaches to this old problem. I would also like
to thank the Association for the privilege of commenting on this
manuscript.
Dr Melo. Dr Damiano, thanks for your comments. I will try to
answer all your questions.
The study design was not biased in the sense that even though
not being prospectively randomized, actually only in one institu-
tion was it prospectively randomized, but in the other institutions
not because this was mostly assigned to the surgeons’ possibility
of doing that, but it was completely blinded regarding the postop-
erative care. And of course, only 15% of the patients had telemetry
during the whole hospital admission, but this happened in both
groups, not only in the group of patients who had denervation. Of
course, I assume that there might have been some episodes of
paroxysmal atrial fibrillation that were not detected, but if so, they
were in the 2 groups and not only in one.
The hospital stay, as I pointed out in this presentation, was the
same in both groups, 8 days. We were also very puzzled with the
question of what we were removing. Were those sympathetic
nerves or parasympathetic nerves? And that is why we decided to
undertake a more profound study that is now being done mostly
in Leiden. It is very puzzling, but as I showed, the number of
nerves is highly variable. When we dissect those nerves off the
heart, which we have done for 1 year in specimens, we see that
some of the fibers are coming from the vagus, the fibers that are
in the plexus of the heart, and some are coming from the
sympathetic chains of the spine. And by trying to stain nerves
and trying to determine whether the nerve was parasympathetic
or sympathetic, we were surprised to see that the axons take
some stain or other, but most intriguing, some of the axons do
not take any stain, and this is a topic of ongoing research. If you
ask me what I believe, I believe at the moment that most nerves
or the nerves of so-called ventral plexus, they are mixed: they
are fibers that are sympathetic and fibers that are parasympa-
thetic.
It has been well documented, not by ourselves but before us at
Washington State by the anesthesia group of Charles Hogue, that
all those patients have dispersion of refractoriness, reduced heart
rate variability, and often frequent atrial ectopy. In our own
groups, we have done tilt tests at 1 and 3 months in selected
patients of both groups, and we could find no difference between
the 2 groups.
Dr H. Schaff (Rochester, Minn). I would like to ask one
question of Dr Melo. You had an incidence of atrial fibrillation in
the control group of 50%, and yet you did not have a difference in
the hospital stay. Was that expected? Was that what you projected?
Dr Melo. No. We had an incidence of 27%, not 50%.
Dr Schaff. And how about the resting heart rate? Was the
resting heart rate after the operation different in the patients who
were denervated versus those who were not, and did you have a
difference in pacing requirements?
Dr Melo. We did not see any difference because this is a
limited denervation, and that is our explanation for not seeing any
effects from this procedure.
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